2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With SchizophreniaCognition Disorders, Cognitive Dysfunction, Psychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, cognitive disorder, psychiatric disorder, schizophreniaNot yet recruitingPhase 32026-05-13NCT07084831
Speech-based Assessment of Relapse Risk in People With PsychosisPsychotic Disorders, Schizophrenia Spectrum and Other Psychotic Disorders, psychiatric disorderRecruitingNot stated2026-02-09NCT07397975